Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
03/2005
03/03/2005US20050048557 Expression vector comprising nucleotide sequences coding microorganismsal protein for use in developing vaccine agents which prevent bacterial infection; bactericides; microbiocides
03/03/2005US20050048528 Using immunoglobulins and diagnostic and/or prognostic tool for detection and treatment of cell proliferative disorders; immunodiagnostics; immunotherapy
03/03/2005US20050048525 Amino acid sequences having hydrolase enzyme activity for use diagnosis, prevention and treatment of cardiovascular and gastrointestinal disorders; drug screening; bioassay
03/03/2005US20050048520 Nogo receptor homologs
03/03/2005US20050048508 Trehalose receptor and method for detecting trehalose with the same
03/03/2005US20050048491 Methods and kits for use in selecting approaches to treating cancer
03/03/2005US20050048488 Expression vector comprising nucleotide sequences coding excitatory amino acid transporter 2 (EAAT2) proteins for use in identifying modulator for treatment and preention of neurological or psychiatric disorder
03/03/2005US20050048484 Cytochrome p450 monooxygenases consisting of thermophilic bacteria
03/03/2005US20050048479 Adenylyl and guanylyl cyclases
03/03/2005US20050048478 Preparing agents which prevent and/or treat viral diseases; immunotherapy; mimetics
03/03/2005US20050048476 Expression vector comprising tumor necrosis factor fusion for use in identifying modulator for treatment of cell proliferaive disorders; antitumor agents
03/03/2005US20050048469 Novel human parvovirus B19 receptor and uses thereof
03/03/2005US20050048464 Method of screening candidate compounds for susceptibility to biliary excretion
03/03/2005US20050048074 Transgenic plant comprising nucleotide sequences coding hemagglutinin-neuraminidase (HN) proteins of newcastle disease viruses; for use in producing immunoprotective particles; vaccine preparation
03/03/2005US20050048068 Major histocompatibility complex epitopes; immunotherapy ; induce immunology response
03/03/2005US20050048064 Chemical modification of single chain polypeptides by means of covalent attachment of strands of polyethylene glycol to single chain polypeptide binding molecules that have three dimensional folding and binding ability
03/03/2005US20050048057 Diagnosis, therapy of cancer, cardiovascular disorders, atherosclerosis, restenosis, osteoporosis, antiinflammatory agents
03/03/2005US20050048055 Use of CD40 engagement to alter T cell receptor usage
03/03/2005US20050048053 Humanization of an anti-carcinoembryonic antigen anti-idiotype antibody as a tumor vaccine and for targeting applications
03/03/2005US20050048052 Bioassay for detecting expression of mammalian CC-chemokine receptor 2, by binding of antibody or antigen-binding fragment; human or humanized monoclonal antibody; test kits
03/03/2005US20050048051 Using mixtuire of antibodies ; aggregated by immobilized streptavidin; culture product
03/03/2005US20050048042 Compositions and methods for the treatment of schizophrenia and addictive disorders
03/03/2005US20050048041 Gene product used for neurodegenerative disorders; homologous recombination; insertion of gene into nucleic acids
03/03/2005US20050048039 Administering exogenous monocyte cells loaded with corrective agent; chemotactic factor for macrophages; diagnosis of bone disorders, anticarcinogenic agents, rheumatic disorders; Alzheimer's disease; Parkinson's disease; Huntington's disease; multiple sclerosis; stroke
03/03/2005US20050048038 Efficient production of f(ab')2 fragments in mammalian cells
03/03/2005US20050048036 Methods of using regenerative cells in the treatment of inherited and acquired disorders of the bone, bone marrow, liver, and other tissues
03/03/2005US20050048035 Methods of using regenerative cells in the treatment of stroke and related diseases and disorders
03/03/2005US20050048034 Using adipose stem cells to treat ischemic ulcer, diabetic and traumatic wounds; regenerative medicine
03/03/2005US20050048033 Using adipose stem cells to treat kidney and urogenital disorders; regenerative medicine
03/03/2005US20050048032 Cell mixture comprising endocrine progenitor cells for use in treatment of diabetes; regenerative medicine and tissue engineering
03/03/2005US20050048031 Defective recombinant adenoviruses expressing cytokines for antitumor treatment
03/03/2005US20050048029 Nucleotide sequence for diagnosis, prevention, therapy of cancer, inflammation, autoimmune disease and infections
03/03/2005CA2848954A1 Compositions containing sertoli cells and myoid cells and use thereof in cellular transplants
03/03/2005CA2537263A1 Techniques and compositions for the diagnosis and treatment of cancer (muc1)
03/03/2005CA2536495A1 Promoter of synoviolin gene
03/03/2005CA2536492A1 Process for producing cytotoxic lymphocytes
03/03/2005CA2536443A1 Device and method for intradermal cell implantation
03/03/2005CA2536239A1 Method for recloning production cells
03/03/2005CA2536152A1 G-csf derivative for inducing immunological tolerance
03/03/2005CA2535921A1 Novel rat calcium channel subunits and related probes, cell lines and methods
03/03/2005CA2535859A1 Endotheliase-2 ligands
03/03/2005CA2535799A1 Identification of porphyromonas gingivalis virulence polynucleotides for diagnosis, treatment, and monitoring of periodontal diseases
03/03/2005CA2535753A1 Neurogenin3 and production of pancreatic islet cells
03/03/2005CA2535745A1 Anti-bacterial composition, especially for controlling gram-negative bacteria, comprising a peptide and an advantageously hydrophobic anti-bacterial agent
03/03/2005CA2535132A1 Plants resistant to cytoplasm-feeding parasites
03/03/2005CA2531400A1 Insecticidal proteins secreted from bacillus thuringiensis and uses therefor
03/03/2005CA2531022A1 Compositions containing sertoli cells and myoid cells and use thereof in cellular transplants
03/03/2005CA2530821A1 Hiv immunogenic complexes
03/03/2005CA2529647A1 Influenza hemagglutinin and neuraminidase variants
03/02/2005EP1510581A1 Nobel glyphosate-tolerant 5-enolpyruvylshikimate-3-phospha synthase and gene encoding it
03/02/2005EP1510580A2 Novel hepatitis C E1 and E2 truncated polypeptides and methods of obtaining the same
03/02/2005EP1510572A2 Isogenic transgenic lines
03/02/2005EP1509610A1 Transgenic plants with controlled distribution of a trait to progeny
03/02/2005EP1509608A1 Methods of purification of cytochrome p450 proteins and of their crystallizing
03/02/2005EP1509607A1 Immunogenic sequences
03/02/2005EP1509606A1 Allergen from mugwort pollen
03/02/2005EP1509603A1 Methods, compositions and kits for cell separation
03/02/2005EP1509598A2 Induction of insulin expression
03/02/2005EP1509597A2 Hair follicle mesenchymal stem cells and use thereof
03/02/2005EP1509596A1 Translocation dependent complementation for drug screening
03/02/2005EP1509595A2 Dendritic cell isolation methods
03/02/2005EP1509594A1 Electrofusion of cells and apparatus therefore
03/02/2005EP1509541A2 Novel recombinant anticoagulant proteins
03/02/2005EP1509540A2 Claudin polypeptides, polynucleotides, and methods of making and use thereof
03/02/2005EP1509539A2 Novel compositions and methods for cancer
03/02/2005EP1509315A2 Materials and reactor systems having humidity and gas control
03/02/2005EP1509253A1 Chimeric cd154
03/02/2005EP1509244A1 New method and composition for producing a cellular allogeneic vaccine
03/02/2005EP1509203A2 Delivery of nucleic acid-like compounds
03/02/2005EP1509087A2 Treatment for diabetes
03/02/2005EP1444331A4 Novel cell-based assays for g-protein-coupled receptor-mediated activities
03/02/2005EP1421115B1 Soluble t cell receptor
03/02/2005EP1390548A4 Cells for detection of enteroviruses
03/02/2005EP1282690B9 Isolation of precursor cells and their use for tissue repair
03/02/2005EP1198475B1 Highly purified cytokine activating factor and methods of use
03/02/2005EP1185656B1 Use of the bnm3 transcriptional activator to control plant embryogenesis and regeneration processes
03/02/2005EP1151156B1 Luciferase reporter bioassay of parathyroid hormone compounds
03/02/2005EP1141294B1 Method of enhancing the biological activity of ligands
03/02/2005EP1140240B1 Injectable hyaluronic acid derivative with pharmaceuticals/cells
03/02/2005EP1140043B1 Transgenic plants comprising a conditionally lethal gene
03/02/2005EP1115852B1 Expression vectors containing hot spot for increased recombinant protein expression in transfected cells
03/02/2005EP1102528A4 Translation control elements for high-level protein expression in the plastids of higher plants and methods of use thereof
03/02/2005EP1066369A4 Selection subtraction approach to gene identification
03/02/2005EP1012319B1 Insect expression vectors
03/02/2005EP0977881B1 Expression of a modified foamy virus envelope protein
03/02/2005EP0959896A4 Human thyrotropin receptor compositions and use thereof
03/02/2005EP0919617B1 Anti-human mp52 monoclonal antibody
03/02/2005EP0907731B1 Metabotropic gaba(b) receptors, receptor-specific ligands and their uses
03/02/2005EP0799311B1 Human chemokine beta-9
03/02/2005EP0759731B1 Device and methods for the in vivo culturing of diverse tissue cells
03/02/2005EP0690916B1 Pesticidal proteins and strains
03/02/2005CN1589330A Stem cells of the islets of langerhans and their use in treating diabetes
03/02/2005CN1589327A Plant enzymes for bioconversion
03/02/2005CN1589321A Apparatus for culturing organism and method of culturing organism
03/02/2005CN1589126A Ectocornea-like sheet and method of manufacturing the same
03/02/2005CN1589103A Nestin-expressing hair follicle stem cells
03/02/2005CN1587415A Rice coronal root control gene CRL3 and its use
03/02/2005CN1587393A Technology for tooth regeneration using keratin stem cell and dental pulp stem cell
03/02/2005CN1587392A External tissue cultivating method for live cell
03/02/2005CN1587391A Process for preparing artificial active skin of skin stem cell collagen sponge film
1 ... 1019 1020 1021 1022 1023 1024 1025 1026 1027 1028 1029 1030 1031 1032 1033 1034 1035 1036 1037 1038 1039 ... 1827